Metabolic evaluation and medical therapy for stone formation

Current Opinion in Urology

Volumn 9, Issue 4, 1999, Pages 335-338

  Krautschick, Andreas W ^a  

^a Gotha City Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CITRIC ACID; CORTICOSTEROID; MAGNESIUM CITRATE;

CALCIUM INTAKE; CHILD; DIET; FEMALE; FRACTURE; GENETIC SUSCEPTIBILITY; HEALTH CARE COST; HUMAN; MALE; METABOLIC DISORDER; NEPHROLITHIASIS; PRIORITY JOURNAL; PUBLIC HEALTH; SHORT SURVEY; URINALYSIS; UROGRAPHY; X RAY CRYSTALLOGRAPHY;

HUMANS; KIDNEY CALCULI; PATIENT SELECTION; RECURRENCE; RISK FACTORS; URINALYSIS;

EID: 0032798438     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199907000-00011     Document Type: Short Survey

References (32)

1. Begun FP, Foley WD, Peterson A, White B. Patient evaluation. Urol Clin North Am 1997; 24:97-116.
2. Levy FL, Adams-Huet B, Pak CYC. Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995; 98:50-59.
3. Coe FL, Keck J, Norton ER. The natural history of calcium urolithiasis. JAMA 1977; 238:15.
4. Ljunghall S. Incidence of ranal stones in Western countries. In. Urolithiasis and related clinical research. Schwille PO, Smith LH, Robertson WG, Vahlensiek W (editors). Plenum Press; 1985, pp. 31-37.
5. Parks JH, Coe FL. The financial effects of kidney stone prevention. Kidney Int 1996; 50:1706-1712.
6. Cicerello E, Merlo F, Gambaro G, et al. Effect of alkaline citrate therapy on clearance of residual stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients. J Urol 1994; 151:5.
7. Tisclius H.G. Curriculum in urology. Infections and stones. Etiology and investigation of stone disease. Eur Urol 1998; 33:1.
8. Brändle E. Urinary calculus-diagnostics. Urologe A 1997; 36:49-56.
9. Curhan GC, Willett WC, Rimm EB, Body size and risk of kidney stones. J Am Soc Nephrol 1998; 9:1645-1652.
10. Leonetti F, Dussol B, Berthezene P, Thirion X, Berland Y. Dietary and urinary risk factors for stones in idiopathic calcium stone formers compared with healthy subjects. Nephrol Dial Transplant 1998; 13:617-622.
11. Santos-Victoriano M, Brouhard BH, Cunningham RJ. Renal stone disease in children. Clin Pediatr 1998; 37:583-599.
12. Esen T, Krautschick AW, Alken P. Update on pediatric nephrolithiasis. World J Urol 1997; 15:195-203.
13. Dalrymple NC Verga M, Andersen KR, Bove P, Covey AM, Rosenfield AT, Smith RC. The value of unenhanced helical computerized tomography in the management of acute flank pain. J Urol 1998; 159:735-740.
14. Dretler S. The value of unenhanced helical computerized tomography in the management of acute flank pain [Comment]. J Urol 1998; 159:740.
15. Mostafavi MR, Randy DE, Saltzman B. Accurate determination of chemical composition of urinary calculi using spiral computerized tomography. J Urol 1998; 159:673-675.
16. Strohmaier WL, Hoelz KJ, Bichler KH. Spot urine samples for the metabolic evaluation of urolithiasis patients. Eur Urol 1997; 32:294-300.
17. Bek-Jensen H, Tiselius HG. Repeated urine analyses in patients with calcium stone disease. Eur Urol 1998; 33:323-332.
18. Hess B, Hasler-Strub U, Ackerman D, Jeager Ph. Metabolic evaluation of patients with recurrent idiopathic calcium nephrolithiasis. Nephrol Dial Transplant 1997; 12:1362-1368.
19. Ackermann DK. Prospective therapeutic studies in nephrolithiasis. World J Urol 1997; 15:172-175.
20. Brockis JG, Vevitt AJ, Cruthers SM. The effects of vegetable and animal protein diets on calcium, urate and oxalate excretion. Br J Urol 1982; 54:290.
21. Hiatt RA, Ettinger B, Caan B, Quesenberry CP, Duncan D, Citron JT. Randomized controlled trial of a low animal protein, high fibre diet in the prevention of calcium kidney stones. Am J Epidemiol 1996; 144:25-33.
22. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993; 328:833-838.
23. Baggio B, Plebani M, Gambaro G. Pothogenesis of idiopathic calcium nephrolithiasis: update 1997. Clin Lab Sci 1998; 35:153-187.
24. Trienchieri A, Nespoli R, Osyini F, Rovera F, Zenetti G, Pisani E. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content. J Urol 1998; 159:654-657.
25. Melton L.J., Crowson CS, Khoshla S, Wilson DM, O'Fallon WM. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998; 53:459-464.
26. Hess B, Jost C, Zipperle L. High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold oxalate load in humans. Nephrol Dial Transplant 1998; 13:2241-2247.
27. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis. J Urol 1996; 155:839-843.
28. Caudarella R, Rizzoli E, Buffa A, Bottura A, Stefoni S. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Ural 1998; 159:664-668.
29. Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F. Effects of mineral composition of drinking water on risks for stone formation and bone metabolism in idiopathic nephrolithiasis. Clin Sci 1996; 91:313-318.
30. Martini LA, Cuppar L, Cunha MA. Potassium and sodium intake and excretion in calcium stone forming patients. J Ren Nutr 1998; 8:127-131.
31. Ettinger B, Pak CYC, Citron JT, Thomas C, Adams-Huet B, Vangessel A. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997; 158:2069-2073.
32. Barceto P, Wuhl O, Servitage E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150:1761.